Enhancing oral delivery of plant-derived vesicles for colitis.
暂无分享,去创建一个
Chun Xing Li | A. Sood | Manu Sebastian | G. Lopez-Berestein | H. Khant | Guodong Zhang | Sixiang Shi | N. Jennings | L. Mangala | E. Bayraktar | J. Braam | Zuliang Jie | Yutuan Wu | P. Schwartz | S. Nagaraju | E. Stur | Yuan Liu | N. N. Bayram | Mamur A. Chowdhury | Natalia de Val | Jody Swain | Mamur A Chowdhury | Cristian Rodríguez-Aguayo | Adrian Lankenau Ahumada | Thanh Chung Vu | Brooke Ermias
[1] A. Cribbs,et al. Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions , 2022, Expert opinion on drug delivery.
[2] Hongzhi Qiao,et al. Technology insight: plant-derived vesicles-how far from the clinical biotherapeutics and therapeutic drug carriers? , 2022, Advanced drug delivery reviews.
[3] Liyong Luo,et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation , 2021, Acta pharmaceutica Sinica. B.
[4] Y. Akimoto,et al. Stability of human salivary extracellular vesicles containing dipeptidyl peptidase IV under simulated gastrointestinal tract conditions , 2021, Biochemistry and biophysics reports.
[5] Zeynep Aytac,et al. Colon targeted delivery of niclosamide from β-cyclodextrin inclusion complex incorporated electrospun Eudragit® L100 nanofibers. , 2020, Colloids and surfaces. B, Biointerfaces.
[6] A. Sood,et al. Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles. , 2020, Nanomedicine : nanotechnology, biology, and medicine.
[7] F. Haidari,et al. Ginger in patients with active ulcerative colitis: a study protocol for a randomized controlled trial , 2020, Trials.
[8] Juan Ye,et al. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth , 2019, Journal of Immunotherapy for Cancer.
[9] C. Xiong,et al. Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention. , 2019, Bioconjugate chemistry.
[10] Y. Takakura,et al. Preservation of exosomes at room temperature using lyophilization , 2018, International journal of pharmaceutics.
[11] F. Şahin,et al. In Vitro Wound Healing Activity of Wheat-Derived Nanovesicles , 2018, Applied Biochemistry and Biotechnology.
[12] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[13] C. Lehr,et al. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying , 2018, Scientific Reports.
[14] B. Muszyńska,et al. Anti-inflammatory properties of edible mushrooms: A review. , 2018, Food chemistry.
[15] Yan Xu,et al. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. , 2018, International journal of biological macromolecules.
[16] J. Suttles,et al. Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[17] S. Srinivasan,et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. , 2016, Biomaterials.
[18] Wei Jiang,et al. Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection. , 2016, Current drug metabolism.
[19] Ashish Jain,et al. Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil , 2015, Materials.
[20] C. McClain,et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage , 2015, Journal of extracellular vesicles.
[21] C. Loddenkemper,et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. , 2014, International journal of clinical and experimental pathology.
[22] Hong Jiang,et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[23] Chang-hao Sun,et al. Cabbage (Brassica oleracea L. var. capitata) phytochemicals with antioxidant and anti-inflammatory potential. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[24] R. Welti,et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] N. Harpaz,et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis‐associated tumorigenesis , 2011, Inflammatory bowel diseases.
[26] U. Schubert,et al. Labeled Nanoparticles Based on Pharmaceutical EUDRAGIT® S 100 Polymers. , 2010, Macromolecular rapid communications.
[27] J. Regenstein,et al. Changes in the antioxidant activity of loach (Misgurnus anguillicaudatus) protein hydrolysates during a simulated gastrointestinal digestion , 2010 .
[28] A. Lopes,et al. A randomized phase II trial of indole‐3‐carbinol in the treatment of vulvar intraepithelial neoplasia , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[29] A. Nyska,et al. Composition, Efficacy, and Safety of Spinach Extracts , 2003, Nutrition and cancer.
[30] Basil Künnecke,et al. Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance , 2002, Magnetic resonance in medicine.
[31] S. Hanauer,et al. New steroids for IBD: progress report , 2002, Gut.
[32] M. Z. Khan,et al. A pH-Dependent Colon-Targeted Oral Drug Delivery System Using Methacrylic Acid Copolymers. II. Manipulation of Drug Release Using Eudragit® L100 and Eudragit S100 Combinations , 2000, Drug development and industrial pharmacy.
[33] M. Z. Khan,et al. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[34] A. Stevenson,et al. 5‐amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine , 1996, Alimentary pharmacology & therapeutics.